Cargando…

Cell-based therapies for age-related macular degeneration: cell replacement versus paracrine effects

Detalles Bibliográficos
Autores principales:	Peng, Xiaoyan, Gao, Ling, Liu, Yongqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224131/ https://www.ncbi.nlm.nih.gov/pubmed/33269782 http://dx.doi.org/10.4103/1673-5374.300443

Ejemplares similares

Paracrine effects of intraocularly implanted cells on degenerating retinas in mice
por: Liu, Xiao, et al.
Publicado: (2020)

Implication of gut microbiome in age-related macular degeneration
por: Luo, Wendy, et al.
Publicado: (2023)

Therapeutic potential of translocator protein ligands for age-related macular degeneration
por: Li, Xing, et al.
Publicado: (2021)

Dental pulp stem cells, a paracrine-mediated therapy for the retina
por: Mead, Ben, et al.
Publicado: (2014)

Inner blood-retina barrier involvement in dry age-related macular degeneration (AMD) pathology
por: Hudson, Natalie, et al.
Publicado: (2020)

A novel approach in preventing vascular leakage and angiogenesis in wet age-related macular degeneration
por: Yamada, Kaori H.
Publicado: (2022)

Characterization of SIRT1/DNMTs Functions and LINE-1 Methylation in Patients with Age-Related Macular Degeneration
por: Maugeri, Andrea, et al.
Publicado: (2019)

A systems biology approach towards understanding and treating non-neovascular age-related macular degeneration
por: Handa, James T., et al.
Publicado: (2019)

Stem cell therapy for retinal ganglion cell degeneration
por: Cen, Ling-Ping, et al.
Publicado: (2018)

Recent advances and future directions for the pharmacogenetic basis of anti-VEGF treatment response in neovascular age-related macular degeneration
por: Riaz, Moeen, et al.
Publicado: (2017)

Neovascular age‐related macular degeneration: A review of findings from the real‐world Fight Retinal Blindness! registry
por: Nguyen, Vuong, et al.
Publicado: (2021)

CasRx-mediated RNA targeting prevents choroidal neovascularization in a mouse model of age-related macular degeneration
por: Zhou, Changyang, et al.
Publicado: (2020)

Trends of Stem Cell Therapies in Age-Related Macular Degeneration
por: Maeda, Tadao, et al.
Publicado: (2021)

Challenges in studying geographic atrophy (GA) age-related macular degeneration: the potential of a new mouse model with GA-like features
por: Ratnayaka, J. Arjuna, et al.
Publicado: (2019)

Gene, Cell and Antibody-Based Therapies for the Treatment of Age-Related Macular Degeneration
por: Akyol, Engin, et al.
Publicado: (2020)

Age-related macular degeneration.
por: McConnell, V., et al.
Publicado: (2005)

Age-related macular degeneration
por: Querques, Giuseppe, et al.
Publicado: (2011)

Age-related macular degeneration
por: Mathenge, Wanjiku
Publicado: (2014)

Sustained neuronal viability by paracrine factors: new opportunities for endothelial progenitor cell secretome
por: Di Santo, Stefano, et al.
Publicado: (2020)

Radiation therapy for neovascular age-related macular degeneration
por: Petrarca, Robert, et al.
Publicado: (2011)

Cellular models and therapies for age-related macular degeneration
por: Forest, David L., et al.
Publicado: (2015)

Future Therapies of Wet Age-Related Macular Degeneration
por: Ishikawa, Makoto, et al.
Publicado: (2015)

Present and Possible Therapies for Age-Related Macular Degeneration
por: Khan, Muhammad, et al.
Publicado: (2014)

Advances in Age-related Macular Degeneration Understanding and Therapy
por: Miller, Joan W, et al.
Publicado: (2017)

Pipeline therapies for neovascular age related macular degeneration
por: Arepalli, Sruthi, et al.
Publicado: (2021)

Recent Advances in Age-Related Macular Degeneration Therapies
por: Fabre, Marie, et al.
Publicado: (2022)

“Complement-ary” Therapies for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022)

Stem cell therapies for age-related macular degeneration: the past, present, and future
por: Dang, Yalong, et al.
Publicado: (2015)

What determines the switch between atrophic and neovascular forms of age related macular degeneration? - the role of BMP4 induced senescence
por: Zhu, DanHong, et al.
Publicado: (2009)

Correlation of Central Versus Peripheral Macular Structure-Function With Acuity in Age-Related Macular Degeneration
por: Sabeti, Faran, et al.
Publicado: (2021)

Efficacy of ranibizumab combined with photodynamic therapy on wet age-related macular degeneration
por: Chen, Ling, et al.
Publicado: (2020)

Pharmacogenetics and Age-Related Macular Degeneration
por: Schwartz, Stephen G., et al.
Publicado: (2011)

Prevention of age-related macular degeneration
por: Wong, Ian Yat Hin, et al.
Publicado: (2010)

Angiogenin in age-related macular degeneration
por: Skeie, Jessica M., et al.
Publicado: (2011)

Pharmacotherapy for Age-Related Macular Degeneration
por: Ahmadieh, Hamid
Publicado: (2008)

Metabolomics and Age-Related Macular Degeneration
por: Brown, Connor N., et al.
Publicado: (2018)

Nanotechnology for Age-Related Macular Degeneration
por: Yang, Bo, et al.
Publicado: (2021)

Neuroprotection for Age-Related Macular Degeneration
por: Lin, Jonathan B., et al.
Publicado: (2022)

Age-Related Macular or Retinal Degeneration?
por: Gałuszka, Michalina, et al.
Publicado: (2023)

Treatment of neovascular age-related macular degeneration: Current therapies
por: Augustin, Albert J, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_v6rb26hgjlu4ilclhqrb2c163g